Skip to content

A Randomized Controlled Study on the Treatment of Obese Polycystic Ovary Syndrome with Acupuncture Based on the Back-shu and Front-mu Acupoints

A Randomized Controlled Study on the Treatment of Obese Polycystic Ovary Syndrome with Acupuncture Based on the Back-shu and Front-mu Acupoints

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001318
Enrollment
Unknown
Registered
2025-07-01
Start date
2025-04-14
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese polycystic ovary syndrome

Interventions

control group:Sham acupuncture+KAP
Waiting for treatment group:KAP
treatment group:acupuncture+KAP

Sponsors

Dongzhimen Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria of Western medicine. 2) Female individuals aged between 18 and 40 years old. 3) Have not taken any hormonal drugs or other medications that may affect the levels of reproductive endocrine hormones within the past three months. 4) The subjects give their informed consent and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients with uterine fibroids, adenomyosis, or ovarian tumors. 2) Patients with impaired liver and kidney function, cardiovascular and cerebrovascular diseases, abnormal adrenal function, diabetes, or thyroid diseases. 3) Patients who have taken oral hormones or used contraceptives within the past three months. 4) Patients with comorbid mental diseases or cancer. 5) Patients with allergic constitution. 6) Subjects with poor compliance or those who cannot attend regular follow-up appointments. 7) Patients who are prone to fainting at the sight of needles or are afraid of needles.

Design outcomes

Primary

MeasureTime frame
Female reproductive hormones;

Secondary

MeasureTime frame
MPCOSQ(Modified PolycysticOvary Syndrome Health Related Quality of Life Questionnaire);SAS (Self-Rating Anxiety Scale);Menstrual cycle score;Body Mass Index (BMI);SF-36 (The 36-Item Short Form Health Survey questionnaire);Menstrual cycle frequency;Blood-fat;GAGS (Global Acne Grading System);SDS(Self-Rating Depression Scale);Number of antral follicles under ultrasound (during the follicular phase of the menstrual cycle);waistline;hipline;mF-G score (modified Ferri-Man-Gallway score);Waist-hip Ratio(WHR);

Countries

China

Contacts

Public ContactCongying Wu

Dongzhimen Hospital, Beijing University of Chinese Medicine

421497055@qq.com15652931956

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026